作者：
Monteleone,J.P.R. [1]
;
Mokhtarani,M. [2]
;
Diaz,G.A. [3]
;
Rhead,W. [4]
;
Lichter-Konecki,U. [5]
;
Berry,S.A. [6]
;
Mons,C.L. [7]
;
Dickinson,K. [8]
;
Coakley,D. [9]
;
Lee,B. ;
Scharschmidt,B.F.
作者单位：
Mt. Sinai School of Medicine, United States
[1]
Baylor College of Medicine, HHMI, Houston, TX, United States
[2]
University of Minnesota, Minneapolis, MN, United States
[3]
Pharsight Corp., Cary, NC, United States
[4]
Hyperion Therapeutics, Inc., South San Francisco, CA, United States, Chief Medical Officer
[5]
Hyperion Therapeutics, Inc., South San Francisco, CA, United States
[6]
Medical College of Wisconsin, Milwaukee, WI, United States
[7]
National Urea Cycle Disorders Foundation, Pasadena, CA, United States
[8]
Children's National Medical Center, Washington, DC, United States
[9]
发布时间
2014-07-31
换一批
